| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |